» Articles » PMID: 30762206

Recommendations for Follow-up of Colorectal Cancer Survivors

Overview
Specialty Oncology
Date 2019 Feb 15
PMID 30762206
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC) is one of the tumours with the highest incidence and mortality in the Spanish population. Nevertheless, the advances in prevention and treatment have contributed to an increased number of patients who survive for prolonged periods of time. In addition, despite recurrences, improved survival following metastasis resection is likewise on the rise. This underscores the importance of carrying out follow-up programmes even in low-risk patients for the early detection of recurrence. The main objective of this article is to provide a set of recommendations for optimising the follow-up of CRC survivors as well as for managing the sequelae that result from either pharmacological or surgical treatment.

Citing Articles

Zebrafish Avatar-test forecasts clinical response to chemotherapy in patients with colorectal cancer.

Costa B, Estrada M, Gomes A, Fernandez L, Azevedo J, Povoa V Nat Commun. 2024; 15(1):4771.

PMID: 38839755 PMC: 11153622. DOI: 10.1038/s41467-024-49051-0.


Significance of Hypermethylation of Tumor-Suppressor Genes PTGER4 and ZNF43 at CpG Sites in the Prognosis of Colorectal Cancer.

Chen C, Wu J, Lin Y, Hsu C, Hu J, Chang P Int J Mol Sci. 2022; 23(18).

PMID: 36142151 PMC: 9499344. DOI: 10.3390/ijms231810225.


Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer.

Herold Z, Herold M, Lohinszky J, Szasz A, Dank M, Somogyi A World J Clin Cases. 2022; 10(20):6825-6844.

PMID: 36051133 PMC: 9297428. DOI: 10.12998/wjcc.v10.i20.6825.


Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness.

Lindenberg M, Kramer A, Kok E, Retel V, Beets G, Ruers T BMC Cancer. 2022; 22(1):504.

PMID: 35524234 PMC: 9074374. DOI: 10.1186/s12885-022-09561-w.


SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021).

Capdevila J, Gomez M, Guillot M, Paez D, Pericay C, Safont M Clin Transl Oncol. 2022; 24(4):646-657.

PMID: 35303269 PMC: 8986677. DOI: 10.1007/s12094-022-02816-9.


References
1.
Meyerhardt J, Mangu P, Flynn P, Korde L, Loprinzi C, Minsky B . Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013; 31(35):4465-70. DOI: 10.1200/JCO.2013.50.7442. View

2.
Grothey A . Oxaliplatin-safety profile: neurotoxicity. Semin Oncol. 2003; 30(4 Suppl 15):5-13. DOI: 10.1016/s0093-7754(03)00399-3. View

3.
Earle C, Neville B . Under use of necessary care among cancer survivors. Cancer. 2004; 101(8):1712-9. DOI: 10.1002/cncr.20560. View

4.
Lee M, Kim J, Kim D, Kang D, Park J, Ahn K . Effect of home-based exercise intervention on fasting insulin and Adipocytokines in colorectal cancer survivors: a randomized controlled trial. Metabolism. 2017; 76:23-31. DOI: 10.1016/j.metabol.2017.07.005. View

5.
Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen M, Extermann M . International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014; 32(24):2595-603. PMC: 4876338. DOI: 10.1200/JCO.2013.54.8347. View